Concord Biotech has informed that the officials of the Company will be Meeting Investors (Participants) as per the schedule enclosed in the file. Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.
